All HIV Aids articles
-
NewsCould Crispr cure HIV?
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at evading eradication
-
BusinessWill HIV prevention get where it’s needed?
Gilead and its partners’ efforts to distribute generic lenacapavir could be derailed by cuts in international aid budgets
-
BusinessUS approves twice yearly injection to prevent HIV
Yeztugo (lenacapavir) provided near-total protection against infection in clinical trials
-
CareersHow Bathabile Ramalapa is making a place for chemistry in health innovation
The award-winning scientist is solving health problems in the global south and inspiring other girls to follow suit
-
BusinessGilead settles US HIV drug kickback lawsuit
Firm will pay $202 million to federal and state governments
-
OpinionHow advances in antiretrovirals have impacted my life with HIV
Eddie Heywood explains how having a range of drugs has helped a whole generation live with HIV – now their biggest concern is remembering to take them
-
ResearchHow HIV drugs have changed over the decades
From one big pill that only prolonged lives a few months, through the 20 pills a day years to modern combination therapies, treating HIV is a science success story
-
BusinessTrials start of mRNA vaccine for HIV
First steps towards protection from the many and variable viral strains
-
-
-
PodcastIminosugars
After some promising results treating ill pets, some researchers think iminosugars could become treatments for infection and even cancer. Mike Freemantle explores the buzz around iminohoney
-
PodcastAzidothymidine
The first drug approved in the US to treat Aids required a completely new approach to clinical trials – Frances Addison explores the history of azidothymidine
-
NewsFears of regulatory backlash in wake of gene-edited babies scandal
Chinese scientist behind birth of twins with edited DNA shows little remorse for his actions
-
FeatureThe quest to cure HIV
Although HIV–Aids can now be managed quite well with antiretroviral drugs, there is still no cure. Anthony King talks to the scientists trying to find one
-
ReviewExhibition: Somewhere in between
Emma Stoye reviews the Wellcome Collection’s exhibition, which promises immersive, science-inspired art installations
-
OpinionWhy combination pills aren’t always the answer
The challenges of medicines containing multiple drugs aren’t going away
-
ResearchBacteria churn out a million potential protein drugs
Modified bacteria produce enormous library of macrocycles, one of which inhibits a HIV protein
-
ResearchRoute to fiendishly complex marine molecule cut in half
Shortcut to promising natural product already in Alzheimer’s and HIV trials
-
FeatureThe long road to an HIV vaccine
A vaccine may not be available anytime soon, but its proponents are hard at work
-
NewsIndia's HIV/Aids law may bring relief to a million people
Legislation aims to tackle stigma of testing and treatment